Feature Channels:

Drugs and Drug Abuse

Add to Favorites Subscribe Share
fbshare-Drugs and Drug Abuse
Press "esc" to clear
Press "esc" to clear
Press "esc" to clear
Go to Advanced Search

Showing results

110 of 672
  • Embargo expired:
    23-Mar-2019 12:00 PM EDT

Article ID: 709658

Another possible consequence of the opioid epidemic: hormone deficiencies

Endocrine Society

Many people who use opioid medications long term do not produce enough testosterone or another important hormone, cortisol, according to a new study. Results of what the researchers called “the most up-to-date and most comprehensive clinical review of endocrine effects of long-term opioid use” are being presented Sunday at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La.

Released:
20-Mar-2019 9:00 AM EDT
PennMed_logo.png

Article ID: 710026

Naltrexone Implant Helps HIV Patients with Opioid Dependence Adhere to Medications, Prevent Relapse

Perelman School of Medicine at the University of Pennsylvania

A new study, published this month in Lancet HIV by Penn Medicine researchers, shows that a naltrexone implant placed under the skin was more effective at helping HIV-positive patients with an opioid addiction reduce relapse and have better HIV-related outcomes compared to the oral drug.

Released:
21-Mar-2019 12:00 PM EDT
AANA_Logo_RGB2.2017.png

Article ID: 710008

Nurse Anesthetists Association Joins Voices for Non-Opioid Choices Coalition

American Association of Nurse Anesthetists (AANA)

The American Association of Nurse Anesthetists (AANA) joins Voices for Non-Opioid Choices, a rising non-partisan coalition group dedicated to to curbing the U.S. opioids crisis by increasing patient access to non-opioid therapies and acute pain management.

Released:
21-Mar-2019 9:00 AM EDT
Embargo will expire:
25-Mar-2019 11:00 AM EDT
Released to reporters:
20-Mar-2019 9:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Mar-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
31-Mar-2019 5:00 AM EDT
Released to reporters:
19-Mar-2019 8:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 31-Mar-2019 5:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

iStock-1026030144.jpg

Article ID: 708911

Fast-Acting Psychedelic Can Improve Depression, Anxiety

Johns Hopkins Medicine

Johns Hopkins researchers have discovered that use of the synthetic psychedelic 5-methocy-N,-N-dimethyltryptamine (5-MeO-DMT) appears to be associated with unintended improvements in self-reported depression and anxiety when given in a ceremonial group setting. 5-MeO-DMT is a psychedelic that is found in the venom of Bufo Alvarius toads, in a variety of plants species, and can be produced synthetically.

Released:
18-Mar-2019 12:00 PM EDT
Surgery_knee_hip_iStock-154956940.jpg
  • Embargo expired:
    16-Mar-2019 3:55 PM EDT

Article ID: 709439

Tip Sheet: Johns Hopkins Researchers Present at Orthopaedic Meeting

Johns Hopkins Medicine

American Academy of Orthopaedic Surgeons 2019 Annual Meeting

Released:
14-Mar-2019 9:00 AM EDT
Moiseaward_2.jpg

Article ID: 709652

Researchers Present New Discoveries in Maternal-Fetal Medicine at National Conference

University of Texas Health Science Center at Houston

New insights into opioid alternatives to treat postpartum pain and medication to delay preterm labor, as well as breakthroughs in spina bifida surgery, were among the topics of research presented at the Society for Maternal-Fetal Medicine’s (SMFM) 39th Annual Pregnancy Meeting by faculty, students, and staff from UTHealth.

Released:
14-Mar-2019 2:35 PM EDT
hms-logo.gif
  • Embargo expired:
    13-Mar-2019 5:00 PM EDT

Article ID: 709406

Dramatic Shifts in First-time Opioid Prescriptions Bring Hope, Concern

Harvard Medical School

Analysis shows the monthly rate of first-time opioid prescriptions dropped by more than half between 2012 and 2017. Though some physicians wrote no new prescriptions at all, others continued to prescribe dosages and durations that put patients at risk for misuse, overdose and death. Findings underscore importance of nuanced, individualized prescribing over all-or-nothing approach.

Released:
11-Mar-2019 1:00 PM EDT
NYULangoneHealthLogo.jpg

Article ID: 709521

Research Points to Ways to Reduce Opioid Use Following Common Orthopedic Surgeries

NYU Langone Health

New research presented American Academy of Orthopaedic Surgeons (AAOS) 2019 reports on the results of a major undertaking by the Department of Orthopedic Surgery at NYU Langone Health to curb opioid prescriptions and usage rates following common orthopedic procedures.

Released:
12-Mar-2019 2:05 PM EDT

Showing results

110 of 672

Chat now!